| LTRN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LTRN shares outstanding history going back to 6/11/2020:
Also see: LTRN Market Cap History LTRN YTD Return |
As of 5/12/2026 Lantern Pharma has 11.30 million LTRN shares outstanding. Investors often track the LTRN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows LTRN share count trends over time, with 26 historical shares outstanding datapoints presented, dating back to 6/11/2020.

| LTRN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LTRN shares outstanding history going back to 6/11/2020:
Also see: LTRN Market Cap History LTRN YTD Return |
| LTRN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
LTRN Historical Shares Outstanding: +11.20% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LTRN Stock Price Chart |
| About Lantern Pharma Inc |
| Lantern Pharma Inc. is an artificial intelligence (AI) company. Co. is developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (ML) platform with multiple clinical-stage drug programs. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 60 billion oncology-focused data points and a library of over 200 advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. We show 26 historical shares outstanding datapoints in our coverage of LTRN's shares outstanding history. Understanding the changing numbers of LTRN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LTRN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LTRN by allowing them to research LTRN shares outstanding history as well as any other stock in our coverage universe. |
| LTRN Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| LTRN Share Performance |
| Shares Outstanding Peers |
| Lantern Pharma (LTRN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
LUCD Shares Outstanding History LUMO Shares Outstanding History LUNG Shares Outstanding History LVGO Shares Outstanding History LXEO Shares Outstanding History LXRX Shares Outstanding History LYEL Shares Outstanding History LYRA Shares Outstanding History MACK Shares Outstanding History MASI Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.